139 related articles for article (PubMed ID: 1336073)
21. Diagnosis of liver cancer from blood sera using FTIR microspectroscopy: a preliminary study.
Thumanu K; Sangrajrang S; Khuhaprema T; Kalalak A; Tanthanuch W; Pongpiachan S; Heraud P
J Biophotonics; 2014 Apr; 7(3-4):222-31. PubMed ID: 24639420
[TBL] [Abstract][Full Text] [Related]
22. Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis.
Xu J; Shi J; Wang YP; Lin Y; Chen YX; Lu J; Zeng X; Xie WF
Med Sci Monit; 2009 Jun; 15(6):CR274-9. PubMed ID: 19478697
[TBL] [Abstract][Full Text] [Related]
23. A study of serological markers and lipid profile in non-alcoholic liver cirrhosis patients.
Khan S; Jamal S
Pak J Pharm Sci; 2018 Jan; 31(1):89-93. PubMed ID: 29348089
[TBL] [Abstract][Full Text] [Related]
24. The role of mean platelet volume in the diagnosis of hepatocellular carcinoma in patients with chronic liver disease.
Kurt M; Onal IK; Sayilir AY; Beyazit Y; Oztas E; Kekilli M; Turhan N; Karaman K; Akdogan M
Hepatogastroenterology; 2012; 59(117):1580-2. PubMed ID: 22683976
[TBL] [Abstract][Full Text] [Related]
25. Plasma prekallikrein levels in patients with hepatocellular carcinoma and liver cirrhosis: a pilot study.
Ciechanowicz A; Kawiak J; Miks B; Dutkiewicz T; Długosz A; Syczewska-Wawrzynowicz M; Marzecka J
Ann Clin Biochem; 1993 Sep; 30 ( Pt 5)():445-8. PubMed ID: 8250496
[TBL] [Abstract][Full Text] [Related]
26. Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis.
Henry L; Lavabre-Bertrand T; Vercambre L; Ramos J; Carillo S; Guiraud I; Pouderoux P; Bismuth M; Valats JC; Demattei C; Duny Y; Chaze I; Funakoshi N; Bureau JP; Daurès JP; Blanc P
Gut; 2009 Jun; 58(6):833-8. PubMed ID: 19201777
[TBL] [Abstract][Full Text] [Related]
27. Validity of alpha fetoprotein for diagnosis of hepatocellular carcinoma in cirrhosis.
Sarwar S; Khan AA; Tarique S
J Coll Physicians Surg Pak; 2014 Jan; 24(1):18-22. PubMed ID: 24411536
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: a possible role in glucocorticoid deficiency.
Spadaro L; Noto D; Privitera G; Tomaselli T; Fede G; Scicali R; Piro S; Fayer F; Altieri I; Averna M; Purrello F
Scand J Gastroenterol; 2015 Mar; 50(3):347-54. PubMed ID: 25592451
[TBL] [Abstract][Full Text] [Related]
29. Serum lipid profiling of patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma by ultra fast LC/IT-TOF MS.
Chen S; Yin P; Zhao X; Xing W; Hu C; Zhou L; Xu G
Electrophoresis; 2013 Oct; 34(19):2848-56. PubMed ID: 24228263
[TBL] [Abstract][Full Text] [Related]
30. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
31. Lecithin:cholesterol acyltransferase, lipids and lipoproteins in maternal and umbilical cord plasma.
Pocoví M; Ordovás JM; Grande F
Artery; 1983; 11(4):264-72. PubMed ID: 6615243
[TBL] [Abstract][Full Text] [Related]
32. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
33. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
[TBL] [Abstract][Full Text] [Related]
34. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.
Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E
Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268
[TBL] [Abstract][Full Text] [Related]
35. Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma.
Buechler C; Aslanidis C
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 May; 1865(5):158658. PubMed ID: 32058031
[TBL] [Abstract][Full Text] [Related]
36. Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma.
Huo TI; Hsu CY; Huang YH; Hsia CY; Lin HC; Lee PC; Loong CC; Chiang JH; Chiou YY; Lee SD
Liver Int; 2010 Feb; 30(2):198-207. PubMed ID: 19849777
[TBL] [Abstract][Full Text] [Related]
37. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract][Full Text] [Related]
38. Diazepam binding inhibitor and total cholesterol plasma levels in cirrhosis and hepatocellular carcinoma.
Venturini I; Zeneroli ML; Corsi L; Baraldi C; Ferrarese C; Pecora N; Frigo M; Alho H; Farina F; Baraldi M
Regul Pept; 1998 Apr; 74(1):31-4. PubMed ID: 9657356
[TBL] [Abstract][Full Text] [Related]
39. [Behavior of total lipids, cholesterol, lipoproteins and apolipoprotein A in the blood of subjects with acute hepatitis and chronic hepatopathy].
Vergani C; Trovato G; Pietrogrande M; Crocchiolo P; Dioguardi N
Minerva Med; 1978 Jun; 69(31):2081-94. PubMed ID: 208025
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and prognostic validity of Golgi protein 73 in hepatocellular carcinoma.
Ozkan H; Erdal H; Tutkak H; Karaeren Z; Yakut M; Yüksel O; Köklü S
Digestion; 2011; 83(1-2):83-8. PubMed ID: 21042019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
